Results 31 to 40 of about 8,269 (200)
Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories
: The 2017 revision of the World Health Organization (WHO) classification includes substantial changes to the subclassification of chronic myelomonocytic leukemia (CMML): (1) a 3-tiered blast-based scheme including a novel “CMML-0” category replacing a 2-
Sanam Loghavi +14 more
doaj +1 more source
Activity of Venetoclax-Based Therapy in CMML and CMML with Blast Transformation
Introduction: There are no standard salvage options for patients (pts) with chronic myelomonocytic leukemia (CMML) after progressing on hypomethylating agents (HMA). Outcomes are especially poor after blast transformation (BT). Combination therapy with the BCL2 inhibitor venetoclax (VEN) has emerged as an efficacious treatment for pts with AML.
Danielle Hammond +19 more
openaire +1 more source
The thin line between CML and CMML [PDF]
![Figure][1] A 57-year-old woman with autosomal dominant polycystic kidney disease, after liver/kidney transplant 2 years ago, presented with complaint of isolated left abdominal discomfort. A complete blood count demonstrated isolated leukocytosis (40 200/µL) with normal platelet count (
Megan Parilla, Girish Venkataraman
openaire +2 more sources
Chronic myelomonocytic leukemia (CMML) is a rare but distinct hematological neoplasm with overlapping features of myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN).
Krishna Gundabolu +8 more
doaj +1 more source
Chronic myelomonocytic leukemia is a clonal chronic hematopoietic disorder that has been classified under the category of Myelodysplastic syndrome/Myeloproliferative neoplasms (MDS/MPN).
Deepti Mutreja +4 more
doaj +1 more source
Chronic myelomonocytic leukemia (CMML) is an entity of myelodysplastic syndrome/myeloproliferative neoplasm. Although CMML can be cured with allogeneic stem cell transplantation, its prognosis is generally very poor due to the limited efficacy of ...
Kazuki Taoka +15 more
doaj +1 more source
: Chronic myelomonocytic leukemia (CMML) is an aggressive myeloid neoplasm of older individuals characterized by persistent monocytosis. Somatic mutations in CMML are heterogeneous and only partially explain the variability in clinical outcomes.
Anca Franzini +8 more
doaj +1 more source
Mutational landscape of chronic myelomonocytic leukemia in Chinese patients
Background Chronic myelomonocytic leukemia (CMML) is a rare and heterogeneous hematological malignancy. It has been shown that the molecular abnormalities such as ASXL1, TET2, SETBP1, and SRSF2 mutations are common in Caucasian population.
Yanbo Nie +10 more
doaj +1 more source
Purpose The prognostic role of TET2 and/or ASXL1 mutations which are common gene mutations in chronic myelomonocytic leukemia (CMML) remains controversial.
Wenxia Zhao +7 more
doaj +1 more source
Practical recommender systems experience a cold-start problem when observed user-item interactions in the history are insufficient. Meta learning, especially gradient based one, can be adopted to tackle this problem by learning initial parameters of the model and thus allowing fast adaptation to a specific task from limited data examples.
Xidong Feng +5 more
openaire +3 more sources

